Anesthesiology and Pain Medicine

Published by: Kowsar

Efficacy of Fentanyl Transdermal Patch in the Treatment of Chronic Soft Tissue Cancer Pain

Karim Hemati 1 , Behrooz Zaman 2 , * , Valliolah Hassani 3 , Farnad Imani 3 and Parviz Dariaie 4
Authors Information
1 Department of Anesthesiology, Imam Khomieni Teaching Hospital, Ilam University of Medical Sciences, Ilam, Iran
2 Department of Anesthesiology, Hazrat Fatemeh Teaching Hospital, Iran University of Medical Sciences, Tehran, Iran
3 Department Of Anesthesiology, Rasool Akram Teachig Hospital, Iran University Of Medical Sciences ,Tehran, Iran
4 Imam Khomeini Teaching Hospital, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Anesthesiology and Pain Medicine: February 01, 2015, 5 (1); e22900
  • Published Online: February 19, 2015
  • Article Type: Research Article
  • Received: August 19, 2014
  • Revised: October 9, 2014
  • Accepted: October 12, 2014
  • DOI: 10.5812/aapm.22900

To Cite: Hemati K, Zaman B, Hassani V, Imani F, Dariaie P. Efficacy of Fentanyl Transdermal Patch in the Treatment of Chronic Soft Tissue Cancer Pain, Anesth Pain Med. 2015 ; 5(1):e22900. doi: 10.5812/aapm.22900.

Abstract
Copyright © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ghavamzadeh A, Moussavi A, Jahani M, Rastegarpanah M, Iravani M. Esophageal cancer in Iran. Semin Oncol. 2001; 28(2): 153-7[PubMed]
  • 2. Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care (Engl). 2007; 16(2): 144-9[DOI][PubMed]
  • 3. Ripamonti CI. Pain management. Ann Oncol. 2012; 23 Suppl 10-301[DOI][PubMed]
  • 4. Kim JH, Kim M, Sung CW, Kim HS, Jang HJ, Shin YC, et al. High-dose fentanyl patch for cancer pain of a patient with cholangiocarcinoma. Korean J Intern Med. 2010; 25(3): 337-40[DOI][PubMed]
  • 5. Park JH, Kim JH, Yun SC, Roh SW, Rhim SC, Kim CJ, et al. Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic D-TRANS) in chronic pain. Acta Neurochir (Wien). 2011; 153(1): 181-90[DOI][PubMed]
  • 6. Koyyalagunta D, Bruera E, Solanki DR, Nouri KH, Burton AW, Toro MP, et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician. 2012; 15(3 Suppl)-58[PubMed]
  • 7. Christo PJ, Mazloomdoost D. Cancer pain and analgesia. Ann N Y Acad Sci. 2008; 1138: 278-98[DOI][PubMed]
  • 8. Keefe FJ, Abernethy AP, C. Campbell L . Psychological approaches to understanding and treating disease-related pain. Annu Rev Psychol. 2005; 56: 601-30[DOI][PubMed]
  • 9. Esmo Guidelines Working Group , Jost L. Management of cancer pain: ESMO clinical recommendations. Ann Oncol. 2007; 18 Suppl 2-4[DOI][PubMed]
  • 10. Nomura M, Kamata M, Kojima H, Hayashi K, Kozai M, Sawada S. Six- versus 12-h conversion method from intravenous to transdermal fentanyl in chronic cancer pain: a randomized study. Support Care Cancer. 2011; 19(5): 691-5[DOI][PubMed]
  • 11. Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage. 1998; 15(3): 168-75[PubMed]
  • 12. Grond S, Zech D, Lehmann KA, Radbruch L, Breitenbach H, Hertel D. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain. 1997; 69(1-2): 191-8[PubMed]
  • 13. Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grond S, et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000; 14(2): 111-9[PubMed]
  • 14. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer. 1999; 86(9): 1856-66[PubMed]
  • 15. Hoya Y, Okamoto T, Yanaga K. Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line. Support Care Cancer. 2010; 18(6): 761-4[DOI][PubMed]
  • 16. Choi HS, Kim KO, Chun HJ, Keum B, Seo YS, Kim YS, et al. The efficacy of transdermal fentanyl for pain relief after endoscopic submucosal dissection: a prospective, randomised controlled trial. Dig Liver Dis. 2012; 44(11): 925-9[DOI][PubMed]
  • 17. Komurcu S, Turhal S, Altundag K, Atahan L, Turna HS, Manavoglu O, et al. Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial. Eur J Cancer Care (Engl). 2007; 16(1): 67-73[DOI][PubMed]
  • 18. Calis KA, Kohler DR, Corso DM. Transdermally administered fentanyl for pain management. Clin Pharm. 1992; 11(1): 22-36[PubMed]
  • 19. Konishi H, Ishihara C, Chiba M, Endo Y, Yamaji A. Pain recurrence on the third day after application of a transdermal fentanyl patch. Pharm World Sci. 2005; 27(4): 353[DOI][PubMed]
  • 20. Kanamori C, Kanamori T, Hayashi M, Yorioka H, Kanzaki H. Three-cycle fentanyl patch system significantly improves pain control in gynecologic cancer. J Obstet Gynaecol Res. 2006; 32(6): 605-9[DOI][PubMed]
  • 21. Kanamori C, Kanamori T, Tanaka Y, Kanzaki H. Three-cycle fentanyl patch system contributes to stable control of plasma fentanyl concentration in gynecologic cancer pain patients. Taiwan J Obstet Gynecol. 2011; 50(1): 79-84[DOI][PubMed]
  • 22. Kornick CA, Santiago-Palma J, Khojainova N, Primavera LH, Payne R, Manfredi PL. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl. Cancer. 2001; 92(12): 3056-61[PubMed]
  • 23. Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med. 2001; 15(4): 309-21[PubMed]
  • 24. Cachia E, Ahmedzai SH. Transdermal opioids for cancer pain. Curr Opin Support Palliat Care. 2011; 5(1): 15-9[DOI][PubMed]
  • 25. Skaer TL. Transdermal opioids for cancer pain. Health Qual Life Outcomes. 2006; 4: 24[DOI][PubMed]
  • 26. Hoy SM, Keating GM. Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain. Drugs. 2008; 68(12): 1711-21[PubMed]
  • 27. Ruoff GE, Rosenthal N, Jordan D, Karim R, Kamin MProtocol, Capss-Study Group. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther. 2003; 25(4): 1123-41[PubMed]
  • 28. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N, Protocol, T. R. P. C. A. N. Study Group . Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol. 2004; 31(12): 2454-63[PubMed]
  • 29. Reed F, Burrow R, Poels KL, Godderis L, Veulemans HA, Mosing M. Evaluation of transdermal fentanyl patch attachment in dogs and analysis of residual fentanyl content following removal. Vet Anaesth Analg. 2011; 38(4): 407-12[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments